Testing Experimental Anti-cancer Drug SLC-391 with an Approved Immunotherapy Drug, Pembrolizumab, for Advanced Lung Cancers

WITHDRAWN

Nashville Oncology Associates, Nashville

RECRUITING

Cleveland Clinic, Cleveland

RECRUITING

Community Health Network, Indianapolis

TERMINATED

Horizon Verdi Oncology, Lafayette

RECRUITING

Karmanos Cancer Center, Detroit

RECRUITING

Nebraska Cancer Specialists, Omaha

RECRUITING

Stephenson Cancer Center, Oklahoma City

RECRUITING

Cross Cancer Institute, Edmonton

RECRUITING

Juravinski Cancer Centre, Hamilton

RECRUITING

London Regional Cancer Centre, London

RECRUITING

Sunnybrook Health Sciences Centre, Toronto

RECRUITING

Jewish General Hospital, Montreal

RECRUITING

McGill University Health Centre, Montreal